Medirom Healthcare Technologies Inc. MRM
Medirom Healthcare Technologies Inc. (MRM) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the distress zone. It does not currently pay a dividend. FY2024 revenue was $8.3B at a 1.8% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Beneish M-score: -0.78 — elevated (above the −1.78 line — aggressive-accounting signals worth a closer look) . A statistical screen for earnings manipulation, not proof — and it doesn't apply to most banks/insurers.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · distress zone
| Component | Value |
|---|---|
| Working capital / assets | -0.182 |
| Retained earnings / assets | 0.028 |
| EBIT / assets | -0.002 |
| Equity / liabilities | 0.143 |
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| MRM | Medirom Healthcare Technologies Inc. | 5/9 | -0.97 | — | +21.5% |
| SCI | SERVICE CORP INTERNATIONAL | 7/9 | 0.42 | 19.3 | +2.9% |
| HRB | H&R BLOCK INC | 7/9 | — | 7.8 | +4.2% |
| UNF | UNIFIRST CORP | 4/9 | 8.12 | 30.9 | +0.2% |
| YELP | YELP INC | 6/9 | 2.26 | 8.8 | +3.7% |
| WW | WW INTERNATIONAL, INC. | 3/9 | 7.04 | — | -11.6% |
| CSV | CARRIAGE SERVICES INC | 5/9 | 1.44 | 12 | +3.3% |
About Medirom Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment develops, owns, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology. This segment operates relaxation salons under the Re.Ra.Ku and Ruam Ruam brands. The Digital Preventative Healthcare segment offers government-sponsored Specific Health Guidance program that utilizes Lav, an on-demand health monitoring smartphone application, as well as MOTHER Bracelet for fitness and health applications; and provides preventative healthcare services utilizing nutritionists and health nurses. The Luxury Beauty segment manages and operates hair salons under the ZACC brand name. The company also operates Re.Ra.Ku College that offers continuing training for franchise owners, home office staff, and salon staff covering topics, such as customer service, salon operations, and relaxation techniques. The company was formerly known as MEDIROM Inc. and changed its name to MEDIROM Healthcare Technologies Inc. in March 2020. MEDIROM Healthcare Technologies Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
FAQ
Is MRM financially healthy?
Medirom Healthcare Technologies Inc.'s Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the distress zone.
Does MRM pay a dividend?
No, Medirom Healthcare Technologies Inc. does not currently pay a dividend.
How profitable is MRM?
In FY2024, Medirom Healthcare Technologies Inc. had a net margin of 1.8% and a return on equity of 15.1%.
Is MRM a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on Medirom Healthcare Technologies Inc.: a Piotroski F-score of 5/9, an Altman Z″ in the distress zone. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.